Logo image of GSRTU

GSR III ACQUISITION CORP (GSRTU) Stock Overview

USA - NASDAQ:GSRTU - KYG4R1031239

10.99 USD
-1.7 (-13.4%)
Last: 10/3/2025, 8:00:01 PM
Fundamental Rating

2

GSRTU gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. The financial health of GSRTU is average, but there are quite some concerns on its profitability. GSRTU does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

GSRTU had positive earnings in the past year.
GSRTU had a negative operating cash flow in the past year.
GSRTU Yearly Net Income VS EBIT VS OCF VS FCFGSRTU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 500K -500K

1.2 Ratios

Industry RankSector Rank
ROA 1.71%
ROE 1.78%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GSRTU Yearly ROA, ROE, ROICGSRTU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 -50 -100 -150

1.3 Margins

GSRTU does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GSRTU Yearly Profit, Operating, Gross MarginsGSRTU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024

More info and screens

5

2. Health

2.1 Basic Checks

The number of shares outstanding for GSRTU has been increased compared to 1 year ago.
GSRTU has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GSRTU Yearly Shares OutstandingGSRTU Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 5M 10M 15M 20M 25M
GSRTU Yearly Total Debt VS Total AssetsGSRTU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 50M 100M 150M 200M

2.2 Solvency

GSRTU has an Altman-Z score of 21.97. This indicates that GSRTU is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for GSRTU. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 21.97
ROIC/WACCN/A
WACCN/A
GSRTU Yearly LT Debt VS Equity VS FCFGSRTU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

GSRTU has a Current Ratio of 1.10. This is a normal value and indicates that GSRTU is financially healthy and should not expect problems in meeting its short term obligations.
GSRTU has a Quick Ratio of 1.10. This is a normal value and indicates that GSRTU is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
GSRTU Yearly Current Assets VS Current LiabilitesGSRTU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 500K 1M 1.5M

More info and screens

1

3. Growth

3.1 Past

GSRTU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 6850.00%, which is quite impressive.
EPS 1Y (TTM)6850%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5533.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, GSRTU will show a very negative growth in Earnings Per Share. The EPS will decrease by -84.51% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-276.3%
EPS Next 2Y-129.65%
EPS Next 3Y-84.51%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GSRTU Yearly EPS VS EstimatesGSRTU Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.05 -0.1 -0.15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 73.27, GSRTU can be considered very expensive at the moment.
Compared to an average S&P500 Price/Earnings ratio of 27.86, GSRTU is valued quite expensively.
GSRTU is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 73.27
Fwd PE N/A
GSRTU Price Earnings VS Forward Price EarningsGSRTU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GSRTU Per share dataGSRTU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

GSRTU's earnings are expected to decrease with -84.51% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-129.65%
EPS Next 3Y-84.51%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GSRTU!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GSR III ACQUISITION CORP

NASDAQ:GSRTU (10/3/2025, 8:00:01 PM)

10.99

-1.7 (-13.4%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-11 2025-08-11
Earnings (Next)12-15 2025-12-15
Inst Owners58.29%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap320.58M
Analysts82.86
Price TargetN/A
Short Float %0%
Short Ratio0.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 73.27
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.41
P/tB 1.41
EV/EBITDA N/A
EPS(TTM)0.15
EY1.36%
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS7.79
TBVpS7.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.71%
ROE 1.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z 21.97
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6850%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5533.33%
EPS Next Y-276.3%
EPS Next 2Y-129.65%
EPS Next 3Y-84.51%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2704.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-1004.19%
EBIT Next 3Y-253.25%
EBIT Next 5YN/A
FCF growth 1Y-2114.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2114.4%
OCF growth 3YN/A
OCF growth 5YN/A